56 filings
8-K
JSPR
Jasper Therapeutics Inc
4 Mar 24
Jasper Therapeutics Reports Fiscal 2023 Financial Results and Recent Corporate Developments
7:40am
8-K
JSPR
Jasper Therapeutics Inc
6 Feb 24
Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock
9:07am
8-K
JSPR
Jasper Therapeutics Inc
4 Jan 24
Material Modifications to Rights of Security Holders
6:04am
8-K
JSPR
Jasper Therapeutics Inc
2 Jan 24
Jasper Therapeutics, Inc. Announces Reverse Stock Split
8:05am
8-K
JSPR
Jasper Therapeutics Inc
20 Dec 23
Submission of Matters to a Vote of Security Holders
6:06am
8-K
rqa34uls6r2 bjf
9 Nov 23
Jasper Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
8:05am
8-K
pj224x16a4za2
1 Nov 23
Jasper Therapeutics Announces Appointment of Thomas G. Wiggans as Chairperson of the Board of Directors
8:00am
8-K
taj4nwsmxdnrmsvv h1
20 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:04am
8-K
tsely6
10 Oct 23
Regulation FD Disclosure
7:00am
8-K
wcb6b0
10 Oct 23
Jasper Therapeutics Announces IND Clearance for Phase 1b/2a Study of Subcutaneous Briquilimab in Chronic Spontaneous Urticaria
6:19am
8-K
ariigem 3ru1
25 Sep 23
Jasper Therapeutics Appoints Herb Cross as Chief Financial Officer
8:00am
8-K
783mqos yuf85u4kr6h
21 Sep 23
Regulation FD Disclosure
8:05am
8-K
8lug8ug69
11 Aug 23
Jasper Therapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update
4:05pm
8-K
tlr3sli rnys3
20 Jun 23
Dr. Brun also appointed as Chairperson of Jasper Research and Development Committee and to Compensation Committee
4:01pm
8-K
2dl0bj1pbk6ulnx0met
8 Jun 23
Departure of Directors or Certain Officers
4:01pm
8-K
nr0rxe7t893q
2 Jun 23
Regulation FD Disclosure
5:03pm
8-K
d7megfsbh6xmocq4c oe
12 May 23
Jasper Therapeutics Reports First Quarter 2023 Financial Results and Provides a Business Update
4:05pm
8-K
aqiu odudi0lsdfoed5
14 Apr 23
Entry into a Material Definitive Agreement
4:05pm
8-K
1vo ohlrpp
8 Mar 23
Jasper Therapeutics Reports Fiscal 2022 Financial Results and Provides a Business Update
4:05pm
8-K
fmgp54x j11y9
17 Feb 23
Departure of Directors or Certain Officers
8:20am